GenMark Submits ePlex Blood Culture ID Gram-Positive Panel for FDA Clearance

Jun 28, 2018

|

NEW YORK (GenomeWeb) – GenMark Diagnostics said Thursday that it has applied to the US Food and Drug Administration for clearance of its ePlex Blood Culture ID – Gram Positive (BCID-GP) panel.

It is the first of three blood culture panels being developed on the ePlex molecular sample-to-answer system for the diagnosis and management of bloodstream infections that can lead to sepsis, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

To Explain What They Mean

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

A Few Days

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

Slightly Larger Pool

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

Cell Studies Explore Microbiome Genes, Tumor Influence, More

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.

Featured White Papers

BlueBee Data Security & Compliance

Menu